Hainan Shuangcheng Pharmaceuticals Co., Ltd. EBITDA for the year ending December 31, 2024: USD -5.95 M

Hainan Shuangcheng Pharmaceuticals Co., Ltd. EBITDA is USD -5.95 M for the year ending December 31, 2024, a 354.60% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Hainan Shuangcheng Pharmaceuticals Co., Ltd. EBITDA for the year ending December 31, 2023 was USD -1.31 M, a -114.84% change year over year.
  • Hainan Shuangcheng Pharmaceuticals Co., Ltd. EBITDA for the year ending December 31, 2022 was USD 8.82 M, a 124.50% change year over year.
  • Hainan Shuangcheng Pharmaceuticals Co., Ltd. EBITDA for the year ending December 31, 2021 was USD 3.93 M, a -355.08% change year over year.
  • Hainan Shuangcheng Pharmaceuticals Co., Ltd. EBITDA for the year ending December 31, 2020 was USD -1.54 M, a -113.23% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)